الصفحة الرئيسية>>Signaling Pathways>> Others>>Imazamox (CL29926)

Imazamox (CL29926)

رقم الكتالوجGC30093

Imazamox (CL29926) (CL29926) هو مبيد أعشاب جهازي يثبط إنتاج سينثاز أسيتولاكتات (ALS) في النباتات ذات الانتقائية العالية والنشاط العالي والأمان ونشاط الطيف العريض ، والذي من شأنه أن يثبط نمو النبات ويؤدي في النهاية إلى موت النبات.

Products are for research use only. Not for human use. We do not sell to patients.

Imazamox (CL29926) التركيب الكيميائي

Cas No.: 114311-32-9

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
52٫00
متوفر
10mg
46٫00
متوفر
50mg
65٫00
متوفر
100mg
83٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Imazamox is an imidazolinone (IMI) herbicides, inhibition of the biosynthesis of acetohydroxyacid synthase, which would then inhibit plant growth and ultimately lead to plant death.increase the GST (The glutathione-S-transferase) activity.in vivo: Half-life of imazamox in the soil ranges from 1 to 3 months exhibit low mammalian toxicity. [1] plants are treated with imazamox (250 μM) in the nutrient solution and harvested 7 days after. Imazamox is mainly accumulated inV. sativa, six fold higher than those detected in P.vulgaris. [2]

[1]. Wei J et al. Enantioselective Phytotoxicity of Imazamox Against Maize Seedlings. Bull Environ Contam Toxicol. 2016 Feb;96(2):242-7. [2]. García-Garijo A et al. Metabolic responses in root nodules of Phaseolus vulgaris and Vicia sativa exposed to the imazamoxherbicide. Pestic Biochem Physiol. 2014 May;111:19-23.

مراجعات

Review for Imazamox (CL29926)

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Imazamox (CL29926)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.